Rachelle Stewart
Medical · Hinton, WVNPI 1891197323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,453 and has fallen 66.6% since, to $486 in 2025.
Across 257 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$774
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$434
- AstraZeneca$401
- GSK$309
- Merck$282
- Boehringer Ingelheim$241
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,191100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $774 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $434 |
| AstraZeneca | 26 | $401 |
| GSK | 18 | $309 |
| Merck | 18 | $282 |
| Boehringer Ingelheim | 16 | $241 |
| Abbott | 11 | $219 |
| AbbVie | 16 | $214 |
| Redhill Biopharma Inc. | 12 | $192 |
| Dexcom, Inc. | 7 | $164 |
| Pfizer | 7 | $126 |
| Amgen | 9 | $119 |
| Lilly USA, LLC | 7 | $110 |
| Novartis | 4 | $71 |
| Verona Pharma, Inc. | 3 | $70 |
| Amarin Pharma, Inc. | 4 | $58 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Almatica Pharma LLC | 3 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Adamas Pharmaceuticals, Inc. | 2 | $28 |
| Bayer | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Biogen | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $6 |
How this compares
$4,191 in reported general payments places this provider in the 85th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $34,378 |
| OzempicSemaglutide | 25 | $30,915 |
| EliquisApixaban | 25 | $20,644 |
| JanuviaSitagliptin Phosphate | 30 | $20,153 |
| EntrestoSacubitril/Valsartan | 16 | $16,086 |
| JardianceEmpagliflozin | 21 | $13,516 |
| TrulicityDulaglutide | 12 | $13,257 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $8,850 |
| VascepaIcosapent Ethyl | 15 | $8,169 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,888 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 89 | $2,614 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,728 |
| Novolog FlexpenInsulin Aspart | 12 | $1,616 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,106 |
| Gabapentin | 108 | $965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $309 | $34,37854 claims |
| Novo NordiskOzempic | $774 | $30,91525 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $241 | $22,36633 claims |
| PfizerEliquis | $126 | $20,64425 claims |
| MerckJanuvia | $282 | $20,15330 claims |
| NovartisEntresto | $71 | $16,08616 claims |
| Lilly USA, LLCTrulicity | $110 | $13,25712 claims |
| AstraZenecaSymbicort | $401 | $3,88813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 233 medical providers in West Virginia.
Other medical in Hinton
- Sara CalesHinton$2K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.